📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Intranasal administration of PTH(1-34) for the treatment of osteoporosis - equivalence to subcutaneous injection at the neck of femur in the Food and Drug Administration (FDA) mandated preclinical model (Oral Presentation - Pearson). (2015)

First Author: Williams AJ

Attributed to: PTH nasal delivery for the treatment of osteoporosis - TSB NINTTO funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Publication URI: http://abstracts.ects-ibms2015.org/ectsibms/0001/ectsibms0001p341.htm

Type: Conference/Paper/Proceeding/Abstract